Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment. On Wednesday, Gilead Sciences, Inc. (GILD) stock ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics, Inc. announced today that the companies have entered into a ...

Parnassus Value Equity Fund stated the following regarding Gilead Sciences, Inc. (NASDAQ:GILD) in its first quarter 2024 investor letter: “Gilead Sciences, Inc. (NASDAQ:GILD), a global ...

PhotonPharma's presentation at the Rocky Mountain Life Sciences Investor and Partnering Conference will provide an overview of the company's progress and development plans. Investors and partners ...

Sept. 4, 2024 /PRNewswire/ -- PhotonPharma, a pioneering biotech company focused on innovative cancer therapies, is pleased to announce its selection as a premier presenting company in the upcoming ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Gilead Sciences reported good quarterly results ... being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those ...